BHC Bausch Health Companies Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BHC

Price (delayed)

$32.97

Market cap

$11.72B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.58

Enterprise value

$33.83B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.bauschhealth.com

Highlights

BHC's EPS has surged by 71% since the previous quarter and by 69% year-on-year
The net income has soared by 71% from the previous quarter and by 69% YoY
The company's equity fell by 50% YoY and by 9% QoQ
Bausch Health Companies's quick ratio has decreased by 15% YoY and by 13% from the previous quarter

Key stats

What are the main financial stats of BHC
Market
Shares outstanding
355.62M
Market cap
$11.72B
Enterprise value
$33.83B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
21.89
Price to sales (P/S)
1.46
EV/EBIT
56.48
EV/EBITDA
13.96
EV/Sales
4.21
Earnings
Revenue
$8.03B
EBIT
$599M
EBITDA
$2.42B
Free cash flow
$802M
Per share
EPS
-$1.58
Free cash flow per share
$2.26
Book value per share
$1.51
Revenue per share
$22.61
TBVPS
$27.35
Balance sheet
Total assets
$31.2B
Total liabilities
$30.59B
Debt
$23.93B
Equity
$535M
Working capital
$429M
Liquidity
Debt to equity
44.72
Current ratio
1.09
Quick ratio
0.69
Net debt/EBITDA
9.12
Margins
EBITDA margin
30.2%
Gross margin
72%
Net margin
-7%
Operating margin
8.4%
Efficiency
Return on assets
-1.8%
Return on equity
-96.8%
Return on invested capital
2.2%
Return on capital employed
2.3%
Return on sales
7.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BHC stock price

How has the Bausch Health Companies stock price performed over time
Intraday
3.35%
1 week
4.93%
1 month
17.21%
1 year
46.86%
YTD
58.51%
QTD
58.51%

Financial performance

How have Bausch Health Companies's revenue and profit performed over time
Revenue
$8.03B
Gross profit
$5.78B
Operating income
$676M
Net income
-$560M
Gross margin
72%
Net margin
-7%
The net income has soared by 71% from the previous quarter and by 69% YoY
The net margin has surged by 71% since the previous quarter and by 66% year-on-year
BHC's gross profit is down by 8% year-on-year
The revenue has declined by 7% year-on-year

Growth

What is Bausch Health Companies's growth rate over time

Valuation

What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
21.89
P/S
1.46
EV/EBIT
56.48
EV/EBITDA
13.96
EV/Sales
4.21
BHC's EPS has surged by 71% since the previous quarter and by 69% year-on-year
BHC's P/B is 97% above its last 4 quarters average of 11.1
The company's equity fell by 50% YoY and by 9% QoQ
The price to sales (P/S) is 83% higher than the 5-year quarterly average of 0.8 and 83% higher than the last 4 quarters average of 0.8
The revenue has declined by 7% year-on-year

Efficiency

How efficient is Bausch Health Companies business performance
The ROA has soared by 70% from the previous quarter and by 67% YoY
The ROE has soared by 64% from the previous quarter but it has contracted by 20% YoY

Dividends

What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BHC.

Financial health

How did Bausch Health Companies financials performed over time
Bausch Health Companies's quick ratio has decreased by 15% YoY and by 13% from the previous quarter
The current ratio has contracted by 9% from the previous quarter and by 2.7% YoY
The debt to equity has surged by 84% year-on-year and by 8% since the previous quarter
The company's equity fell by 50% YoY and by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.